2016/04/14 – 2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces that its 2015 annual report is available and issues a report on the highlights from 2015 and the start of 2016.

[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2016/04/QUANTUM_PR_2015-annual-results_20160414_EN-VF.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]